Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report)'s stock price gapped up before the market opened on Monday . The stock had previously closed at $28.00, but opened at $29.63. Phibro Animal Health shares last traded at $29.99, with a volume of 61,889 shares traded.
Wall Street Analyst Weigh In
PAHC has been the subject of several research analyst reports. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and lifted their price objective for the company from $25.00 to $35.00 in a research note on Monday. Morgan Stanley set a $26.00 price objective on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a research report on Wednesday, June 25th. Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target on the stock in a research report on Monday, June 16th. Finally, BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $24.40.
Check Out Our Latest Stock Analysis on PAHC
Phibro Animal Health Price Performance
The stock has a market cap of $1.22 billion, a PE ratio of 38.62, a P/E/G ratio of 0.50 and a beta of 0.75. The firm's fifty day moving average price is $23.83 and its 200 day moving average price is $22.19. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. The firm had revenue of $347.80 million for the quarter, compared to analysts' expectations of $352.41 million. As a group, equities analysts expect that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.
Phibro Animal Health Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th were paid a $0.12 dividend. The ex-dividend date was Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a yield of 1.59%. Phibro Animal Health's payout ratio is 61.54%.
Hedge Funds Weigh In On Phibro Animal Health
Institutional investors have recently made changes to their positions in the company. Nuveen LLC purchased a new position in Phibro Animal Health during the 1st quarter valued at about $10,312,000. Invesco Ltd. increased its holdings in Phibro Animal Health by 92.3% during the first quarter. Invesco Ltd. now owns 387,739 shares of the company's stock valued at $8,282,000 after buying an additional 186,087 shares during the period. Axecap Investments LLC purchased a new position in Phibro Animal Health during the first quarter valued at approximately $3,696,000. Millennium Management LLC increased its holdings in Phibro Animal Health by 74.3% during the first quarter. Millennium Management LLC now owns 362,030 shares of the company's stock valued at $7,733,000 after buying an additional 154,281 shares during the period. Finally, Jacobs Levy Equity Management Inc. increased its holdings in shares of Phibro Animal Health by 56.7% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company's stock valued at $6,325,000 after acquiring an additional 108,918 shares during the period. Hedge funds and other institutional investors own 99.34% of the company's stock.
Phibro Animal Health Company Profile
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Stories
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
